BCL2L14
Apoptosis facilitator Bcl-2-like protein 14
Also known as: B2L14_HUMAN, BCL-G, BCLG
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BZR8
- Gene
- BCL2L14
- Ensembl
- ENSG00000121380
- Chromosome
- 12
- Canonical length
- 327 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
OverviewNCBI Gene
The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. Overexpression of this gene has been shown to induce apoptosis in cells. Three alternatively spliced transcript variants encoding two distinct isoforms have been reported for this gene. [provided by RefSeq, May 2009]
Canonical amino-acid sequenceUniProt
327 residues, UniProt reviewed canonical sequence.
>Q9BZR8|BCL2L14
1 MCSTSGCDLE EIPLDDDDLN TIEFKILAYY TRHHVFKSTP ALFSPKLLRT RSLSQRGLGN
61 CSANESWTEV SWPCRNSQSS EKAINLGKKK SSWKAFFGVV EKEDSQSTPA KVSAQGQRTL
121 EYQDSHSQQW SRCLSNVEQC LEHEAVDPKV ISIANRVAEI VYSWPPPQAT QAGGFKSKEI
181 FVTEGLSFQL QGHVPVASSS KKDEEEQILA KIVELLKYSG DQLERKLKKD KALMGHFQDG
241 LSYSVFKTIT DQVLMGVDPR GESEVKAQGF KAALVIDVTA KLTAIDNHPM NRVLGFGTKY
301 LKENFSPWIQ QHGGWEKILG ISHEEVDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BCL2L14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- testis: 30 nTPM
- rectum: 15 nTPM
- duodenum: 13 nTPM
- small intestine: 12 nTPM
- colon: 10 nTPM
- stomach: 8.8 nTPM
Single-cell type
- late spermatids: 276 nCPM
- early spermatids: 86 nCPM
- oligodendrocytes: 48 nCPM
- oligodendrocyte progenitor cells: 44 nCPM
- late primary spermatocytes: 40 nCPM
- loop of henle epithelial cells: 40 nCPM
Immune cell
- T-reg: 0.7 nTPM
- memory CD4 T-cell: 0.3 nTPM
- memory B-cell: 0.2 nTPM
- naive CD4 T-cell: 0.2 nTPM
- MAIT T-cell: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
Brain region
- cerebral cortex: 1.3 nTPM
- amygdala: 1.2 nTPM
- hippocampal formation: 1.2 nTPM
- medulla oblongata: 1.2 nTPM
- choroid plexus: 1.1 nTPM
- basal ganglia: 1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.11
- gnomAD pLI
- 0
- gnomAD missense Z
- 0
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- positive regulation of extrinsic apoptotic signaling pathway
- regulation of apoptotic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BCL2L14 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BCL2L14 as an antibody target. Whether an autoantibody or antibody against BCL2L14 could matter depends on whether native BCL2L14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BCL2L14 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BCL2L14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...